A pioneer in modified risk tobacco products, Philip Morris International is the only company to have received a modified risk marketing claim for an electronic nicotine device. FDA concludes “Evidence continues to support the modified exposure claim that ‘Scientific studies have shown that switching completely from conventional cigarettes to the IQOS system significantly reduces your … [Read more…]

MONTREAL–(BUSINESS WIRE)–Driven by its ambition to expand its portfolio and inspired by the surging popularity of canned coffee in North America, Second Cup has partnered with Labatt Breweries of Canada and Station Agro-Biotech to introduce a locally made innovation to grocery shelves: a premium line of canned ready-to-drink lattes. Offered in three flavours, Latte, Mocha, … [Read more…]

New Amazon Pharmacy Kiosks debut at One Medical offices in Los Angeles, helping patients start treatment faster and improve medication adherence SEATTLE–(BUSINESS WIRE)–Amazon Pharmacy (NASDAQ: AMZN) today announced the launch of Amazon Pharmacy Kiosks, an innovative new service that allows patients to pick up prescriptions within minutes of their medical appointment. Beginning December 2025, kiosks … [Read more…]

Lab equipment scheduling platform supporting pharma and life sciences R&D organisations’ AI journey amidst industry upheaval LONDON–(BUSINESS WIRE)–Clustermarket, the lab equipment scheduling platform, has today announced it is rebranding to Calira and welcoming non-executive director and investor Edmund Wilson, co-founder and former CEO of Titian Software (now Cenevo), to capitalise on increasing enterprise demand for … [Read more…]

OSAKA, Japan–(BUSINESS WIRE)–#medical–Gunze Limited (Headquarters: Osaka, Japan; President: Toshiyasu Saguchi) [TOKYO:3002] is pleased to announce that its wholly owned subsidiary, Gunze Medical Limited (Headquarters: Osaka, Japan; President: Shojiro Matsuda) and HistoSonics, Inc. (Headquarters: Minneapolis, MN USA; CEO: Mike Blue) have entered into an agreement to exclusively distribute a noninvasive platform and proprietary sonic beam therapy … [Read more…]

New facility will expand accessibility for HIV/AIDS specialty services, free STI/STD prevention and treatment services, primary medical care and access to non-profit pharmacy services Ribbon-cutting ceremony with local dignitaries scheduled for Wednesday, October 8, 2025, at 10:30am at 4299 Elvis Presley Boulevard, Memphis, TN. Current statistics indicate Memphis, nationally, ranks 2nd in new HIV diagnosis, … [Read more…]

Funding and product launch advance company’s efforts to make high-quality, affordable healthcare accessible to all Americans NEW YORK–(BUSINESS WIRE)–Nava Benefits today announced the launch of HQ, the industry’s first AI-powered benefits platform built to eliminate benefits busy work for HR teams, deliver a powerful renewal experience that unifies quoting, benchmarking and demographics, and gives HR … [Read more…]

ONTARIO, Calif.–(BUSINESS WIRE)–Prime Healthcare Services will report earnings the morning of November 11, 2025, to be followed by a conference call at 2:00 p.m. (ET) to discuss the reported results. Please ensure you pre-register prior to the call by emailing EGarcia27@primehealthcare.com to facilitate attaining your individual pin that will allow direct access to the call. … [Read more…]

-Oral Presentation at ESGCT Highlights Potential of JCR’s Proprietary JUST-AAV Platform to Facilitate More Efficient Delivery While Reducing Liver Tropism- HYOGO, Japan–(BUSINESS WIRE)–JCR Pharmaceuticals Co., Ltd. (TSE 4552; “JCR”), a global specialty biopharmaceutical company dedicated to developing therapies for rare and genetic diseases, today presented non-clinical data demonstrating the ability of its proprietary JUST-AAV capsid … [Read more…]

BOSTON–(BUSINESS WIRE)–#AASLD–nChroma Bio (“nChroma”), a genetic medicines company advancing in vivo delivery of innovative cargoes to overcome the limitations of existing therapies, today announced the acceptance of three abstracts, including a poster of distinction, at the upcoming AASLD Liver Meeting®, taking place November 7 to 11, 2025, in Washington, D.C. “At AASLD, we’re showcasing the … [Read more…]